Unknown

Dataset Information

0

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.


ABSTRACT: The objective of this prospective study was to assess short- and long-term efficacy of exercise training (ET) as add-on to medical therapy in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-APAH).Patients with invasively confirmed CTD-APAH received ET in-hospital for 3 weeks and continued at home for 12 weeks. Efficacy parameters have been evaluated at baseline and after 15 weeks by blinded-observers. Survival rate has been evaluated in a follow-up period of 2.9 ± 1.9 years.Twenty-one consecutive patients were included and assessed at baseline, and after 3 weeks, 14 after 15 weeks. Patients significantly improved the mean distance walked in 6 minutes compared to baseline by 67 ± 52 meters after 3 weeks (p < 0.001) and by 71 ± 35 meters after 15 weeks (p = 0.003), scores of quality of life (p < 0.05), heart rate at rest, peak oxygen consumption, oxygen saturation and maximal workload. Systolic pulmonary artery pressure and diastolic systemic blood pressure improved significantly after 3 weeks of ET. The 1- and 2-year overall-survival rates were 100%, the 3-year survival 73%. In one patient lung transplantation was performed 6 months after ET.ET as add-on to medical therapy is highly effective in patients with CTD-APAH to improve work capacity, quality of life and further prognostic relevant parameters and possibly improves the 1-, 2- and 3-year survival rate. Further randomized controlled studies are needed to confirm these results.ClinicalTrials.gov: NCT00491309.

SUBMITTER: Grunig E 

PROVIDER: S-EPMC3446533 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Introduction</h4>The objective of this prospective study was to assess short- and long-term efficacy of exercise training (ET) as add-on to medical therapy in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-APAH).<h4>Methods</h4>Patients with invasively confirmed CTD-APAH received ET in-hospital for 3 weeks and continued at home for 12 weeks. Efficacy parameters have been evaluated at baseline and after 15 weeks by blinded-observers. Survival rate has  ...[more]

Similar Datasets

| S-EPMC5593379 | biostudies-literature
| S-EPMC3883571 | biostudies-literature
| S-EPMC3733303 | biostudies-literature
| S-EPMC6405825 | biostudies-literature
| S-EPMC7155785 | biostudies-literature
| S-EPMC8231632 | biostudies-literature
| S-EPMC9341111 | biostudies-literature
| S-EPMC3882308 | biostudies-literature
| S-EPMC8278470 | biostudies-literature
| S-EPMC8612911 | biostudies-literature